hematology and oncology
Cutaneous T cell Lymphomas (CTCL)
Prognosis for Cutaneous T cell Lymphomas
Most patients are>50 years at diagnosis. Survival rates vary markedly depending on stage at diagnosis. Patients who receive treatment for stage IA disease have a life expectancy analogous to that of similar people without mycosis fungoides. Patients with stage II disease have a median survival > 5 years, while those diagnosed with stage IV disease survive for just over 2 years. 